These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 4277393

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cell-mediated lympholysis. Importance of serologically defined H-2 regions.
    Alter BJ, Schendel DJ, Bach ML, Bach FH, Klein J, Stimpfling JH.
    J Exp Med; 1973 May 01; 137(5):1303-9. PubMed ID: 4267208
    [Abstract] [Full Text] [Related]

  • 24. T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.
    Wagner H, Röllinghoff M, Nossal GJ.
    Transplant Rev; 1973 May 01; 17(0):3-36. PubMed ID: 4151904
    [No Abstract] [Full Text] [Related]

  • 25. Cell-mediated immune response in rats during acute allograft rejection and in rats developing allograft acceptance due to passive enhancement.
    Heron I, Meyer H.
    Tissue Antigens; 1973 May 01; 3(4):348-51. PubMed ID: 4272113
    [No Abstract] [Full Text] [Related]

  • 26. Stimulation and reactivity of leukaemic cells in acute myeloid leukaemia.
    Pegrum GD, Evans CA, Middleton VL.
    Acta Haematol; 1974 May 01; 51(3):129-39. PubMed ID: 4281988
    [No Abstract] [Full Text] [Related]

  • 27. Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse.
    Nabholz M, Vives J, Young HM, Meo T, Miggiano V, Rijnbeek A, Shreffler DC.
    Eur J Immunol; 1974 May 01; 4(5):378-87. PubMed ID: 4277395
    [No Abstract] [Full Text] [Related]

  • 28. The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man.
    Eijsvoogel VP, du Bois MJ, Meinesz A, Bierhorst-Eijlander A, Zeylemaker WP, Schellekens PT.
    Transplant Proc; 1973 Dec 01; 5(4):1675-8. PubMed ID: 4130075
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunogenetic disparity and graft-versus-host reactions.
    Bach ML, Bach FH.
    Semin Hematol; 1974 Jul 01; 11(3):291-303. PubMed ID: 4151845
    [No Abstract] [Full Text] [Related]

  • 32. The histocompatibility complex of rhesus monkeys. II. A major locus controlling reactivity in mixed lymphocyte cultures.
    Balner H, Toth EK.
    Tissue Antigens; 1973 Jul 01; 3(4):273-90. PubMed ID: 4272109
    [No Abstract] [Full Text] [Related]

  • 33. Inhibition of lymphocyte proliferative responses by anti-HL-A alloantisera.
    Brochier J, Roitt IM, Festenstein H.
    Eur J Immunol; 1974 Nov 01; 4(11):709-15. PubMed ID: 4279178
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Specific in vitro elimination of histocompatibility antigen reactive cells (HARC).
    Hirschberg H, Thorsby E.
    J Immunol Methods; 1973 Nov 01; 3(3):251-63. PubMed ID: 4271931
    [No Abstract] [Full Text] [Related]

  • 36. Modulation of cell-mediated lympholysis by alloantisera.
    Cordier G, Betuel H, Revillard JP.
    Transplant Proc; 1973 Dec 01; 5(4):1855-7. PubMed ID: 4272833
    [No Abstract] [Full Text] [Related]

  • 37. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ, Bach FH.
    Transplant Proc; 1972 Sep 01; 4(3):307-10. PubMed ID: 4263510
    [No Abstract] [Full Text] [Related]

  • 38. Cellular reactivities associated with theta-antigen disparity.
    Peck AB, Bach FH, Boyse EA.
    Transplant Proc; 1973 Dec 01; 5(4):1611-3. PubMed ID: 4272820
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.